Don Perata?s Farewell Message as a Senator California Progress Report, CA - Nov 29, 2008 In 1997, we convinced Governor Wilson to create the ovarian and prostate cancer fund. For many years, this fund allocated $27 million annually toward ...
Why new government must curb CEO pay MSNBC - Nov 5, 2008 Yes this particular cancer ? which has been growing exponentially for almost two decades ? is at the core of many of our nation's economic ills. ...
A New Sexual Agenda CounterPunch, CA - Nov 28, 2008 In a 2006 report, the Boston Globe found that since 1994 a total of 9682 soldiers have been discharged on sexual ground. It reports that ?the number of ...
Third runway opponents see victory in concessions Seattle Post Intelligencer - Nov 13, 2008 Puget Sound Clean Air Agency programs to curb particulate matter from burning diesel fuel and wood also help address air toxics, McLerran said. ...
Reasons to quit Lower Hudson Journal news, NY - Nov 20, 2008 Young people are getting plenty of attention in the fight to curb tobacco use. Westchester, Putnam and Rockland counties host Reality Check partnerships ...
Ukraine-Pa. hospitals relationship mulled Wilkes Barre Times-Leader, PA - She said she wants to see cooperation between American and Ukrainian doctors, particularly in cancer research. Cancer is a major concern in Ukraine 22 years ...
Online Resources Posts Second Quarter 2008 Results WELT ONLINE, Germany - Jul 29, 2008 Online Resources Corporation (Nasdaq:ORCC), a leading provider of web-based financial services, today reported financial and operating results for the three ...ORCC
Quarterly Activities Report Sydney Morning Herald, Australia - Jul 27, 2008 BH08003 Blue Hills 143.3m portion of hole only , 100.6m @ 0.41% Cueq, including 30.5m @ 0.51% Cueq BH08004 Blue Hills RC pre-collar DD tail to be NSR in RC ...
EMCOR Group, Inc. Reports Record Second Quarter Results MarketWatch - Jul 29, 2008 This press release and other press releases may be viewed at the Company's Web site at www.emcorgroup.com. EMCOR Group's second quarter conference call will ...EME
Littelfuse Reports Second Quarter Results MarketWatch - Jul 30, 2008 The call will be broadcast live over the Internet and can be accessed through the company's Web site: www.littelfuse.com. Listeners should go to the Web...LFUS
[PDF]Focused crawling: A new approach to topic-specific Web resource discovery - S Chakrabarti, M van den Berg, B Dom - COMPUT. NETWORKS, 1999 - cse.iitb.ac.in ... 1b, each red dot is a Web page, which may be viewed in a browser window ... operators (
+-L" ); an average Alta Vista query has only 2.35 terms and 0.41 operators ...
A Meta-Analysis of Response Rates in Web-or Internet-Based Surveys - C Cook, F Heath, RL Thompson - Educational and Psychological Measurement, 2000 - epm.sagepub.com ... For these populations, e-mail and Web surveys may have only minor coverage problems ...
0.21 0.41 .372 ?.188 .055 ?.287 .101 ?.504 .021 .045 ?.208 .294 .374 ...
Real life information retrieval: a study of user queries on the Web - BJ Jansen, A Spink, J Bateman, T Saracevic - ACM SIGIR Forum, 1998 - portal.acm.org ... But in any case, this, of course, has interesting implications for recall and may
illustrate a need for high precision in Web IR algorithms ... 11 75 0.41 33 1 0.01 ...
Analysis of a very large web search engine query log - C Silverstein, H Marais, M Henzinger, M Moricz - ACM SIGIR Forum, 1999 - portal.acm.org ... of all queries are asked only once in a 6 week period indi- cates that information
needs on the web are quite ... 1 operator in query: 9.7% avg operators: 0.41...
Untangling the Web: Using Price-Response Measures in Enrollment Projections - EPS John - The Journal of Higher Education, 1993 - JSTOR ... In this article I attempt to untangle the web of controversy surrounding the use ...
NS ** Persistence Price Response [48] First-to-second year NA NS 0.41 0.23 NS ...
The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of … - DP Spence, SL Johnston, PM Calverley, P Dhillon, C … - American Journal of Respiratory and Critical Care Medicine, 1994 - Am Thoracic Soc ... during the treatment phase but this was almost identical in the WEB 2086 and ... by an
increase in symptoms correlated with disease duration (r = 0.41, p < 0.01 ...
[PDF]WebQual: a measure of Web site quality ET Loiacono, RT Watson, DL Goodhue - 2002 Marketing Educators? Conference: Marketing Theory and …, 2002 - terry.uga.edu Page 1. 1 WebQual?: A Measure of Web Site Quality Eleanor T. Loiacono ... 0037
Page 2. 2 WebQual?: A Measure of Web Site Quality Eleanor T ...
Classification of Web documents using a naive Bayes method - Y Wang, J Hodges, B Tang - Tools with Artificial Intelligence, 2003. Proceedings. 15th …, 2003 - ieeexplore.ieee.org ... example, in [13], the total number of categories used by Quek?s web document
classification ... 0.25 0.25 0.1 0.17 0.3 0.87 0.99 0.29 0.46 0.2 0.2 0.41 0.87 0.92 ...
Source: Google Scholar
Fruit research yields way to curb cancer
Last Updated: 2006-07-03 8:30:41 -0400 (Reuters Health)
JERUSALEM - Scientists at an Israeli university have found a promising new way to stop the growth and spread of cancer cells while carrying out research to boost the size of peaches and nectarines, the university said on Sunday.
The Hebrew University of Jerusalem scientists found that a protein similar to one researched in their project had the effect of blocking blood supply to tumours.
"By blocking the blood supply to the tumours, actibind halted the ability of malignant cells to move through the blood stream," the university said.
"Their approach has been shown to inhibit the malignant cells without affecting normal cells and without the severe side effects of traditional treatments such as radiation and chemotherapy," it said.
Oded Shoseyov, who led the research, told Reuters his team had succeeded in using the protein to reduce the number of fruits on a tree, thereby increasing the size of each fruit. The technique worked by inhibiting the growth of pollen cells.
"We hypothesised that since the mechanism of growth is very similar -- between the pollen cell and the cancer cell -- that the protein would have the same effect," he said.
Shoseyov's team had used genetic engineering to produce a variant of the protein "that showed an impressive anti-cancer potential", the university said.
"These results have raised broad interest in international scientific meetings and in business circles," it said.
No link seen between anthrax shots and eye ailment
Last Updated: 2006-07-03 11:04:36 -0400 (Reuters Health)
NEW YORK (Reuters Health) - Vaccine postmarketing surveillance among U.S. military personnel does not show any association between inflammation of the optic nerve, also called optic neuritis, and immunization against anthrax, smallpox, hepatitis B, or influenza, regardless of whether these vaccines are administered alone or in combination, investigators report.
There have been a number of case reports of a potential association between optic neuritis and receipt of these vaccines, Dr. Daniel C. Payne from the Centers for Disease Control and Prevention, Atlanta, and colleagues explain in a report in Archives of Neurology.
To investigate further, they conducted a matched case-control study within the U.S. military. Analyses centered on 1,131 cases of optic neuritis and 3,393 controls matched by sex, military component, and deployment status.
The investigators calculated optic neuritis risks at 6-, 12-, and 18-weeks post vaccination intervals, given that onset of vaccine-mediated optic neuritis would typically occur within several weeks after vaccination, they explain.
Payne and colleagues could find no statistically significant associations between optic neuritis and vaccination with anthrax, smallpox, hepatitis B, and influenza vaccines for any of the three study intervals.
There were also no statistically significant vaccine interactions.
"With questions concerning the safety of anthrax vaccine raised by the media, by some scientists, and by some members of the Armed Forces, the negative findings presented here are important to this vaccine's continuing safety discussion," the authors conclude.
